OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Consider a matrix of factors when choosing the type of cleanroom facility.
Advanced analytics reveals process insights.
Technology protects the supply chain from manufacturer to patient.
Expert help is crucial for drug sponsors that design their own facilities.
March 03, 2021
With funding from the federal government, Merck will expand capacity to produce J&J’s COVID-19 vaccine.
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.
Integrated, paperless data systems can improve efficiency and quality.
The need for real-time monitoring and control has spurred the development of new analytical tools.
AstraZeneca has announced that the mass rollout of its COVID-19 vaccine has begun via the COVAX initiative.
March 02, 2021
The rapid and efficient delivery of innovative treatments through the COVID-19 pandemic has demonstrated the value of collaborations within the bio/pharma industry.
More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.
March 01, 2021
Distribution of the first one-dose vaccine for COVID-19 to start in early March.
Currently, the facility manufactures products for oral diabetes treatment and will be expanded to increase capacity for these products.